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Summary
 
Although much is known about the activation, proliferation, and function of CD4
 
1
 
 T cells, lit-
tle is known about how they survive as resting T cells in animals. Resting T cells have a half-life
in animals of more than a week; however, when they are removed from animals and placed in
tissue culture their half-life falls to 
 
z
 
24 h. In this paper, we show that the survival of resting T
cells in vitro is promoted by two cytokines, interleukins 4 and 7 (IL-4, IL-7). They may do this
in part by maintaining levels of survival-promoting proteins such as Bcl-2 in the cells, because
the levels of Bcl-2 and Bcl-X
 
l
 
 in resting T cells fall rapidly after the cells are isolated from ani-
mals, and are maintained by culture in IL-4. Because the IL-4 receptor is known to signal
through the JAK1 and JAK3/Stat6 pathway, we tested whether Stat6 was required for IL-4–
dependent T cell survival. Surprisingly, we found that IL-4 rescued T cells from apoptosis in
what appeared to be a Stat6-independent manner. These results demonstrate that the survival
of resting T cells is an active process that can be affected by signals delivered by cytokines and
also suggest that the IL-4 receptor on resting T cells may use a novel signaling pathway to facil-
itate T cell viability.
 
M
 
any investigators have studied the life expectancy of
B and T cells (1–5). Some aspects of this subject are
very controversial; for example, argument continues to
rage over the matter of whether immunological memory
depends upon lymphocyte proliferation in response to anti-
gen stored in the animal versus a very long half-life for
memory cells (5). Even for virgin cells, the question of half-
life is not settled. Early studies suggested that a population
of T cells in unprimed mice might have a half-life of only
 
z
 
2 wk (6); however, later studies have suggested that some
virgin T cells may have life expectancies that are longer
than this (3–5). In general, most students of this subject
would agree that virgin, nondividing T cells have half-lives
in vivo that are at least several weeks in length.
Although a good deal is known about what keeps acti-
vated T cells alive, surprisingly little is known about what is
needed to maintain resting T cells in animals. Of course, it
is possible that these cells receive no external signals, and
that their half-lives in vivo are simply a reflection of their
own internal clocks. Two results suggest that this simple
hypothesis may not be correct. First, the half-life of periph-
eral T cells in animals is shortened if the cells do not express
the 
 
g
 
 chain (
 
g
 
c; reference 7), which is common to the re-
ceptors for a number of cytokines including IL-2, IL-4, IL-7,
IL-9, and IL-15 (8–10). Second, the life expectancy of iso-
lated virgin T cells is much shorter in tissue culture than it
is in animals. In vitro, isolated T cells have a half-life of
only 1–2 d, rather than the half-life of 2 wk or more found
in vivo. Although this latter result could be due to inade-
quate tissue culture conditions, it is also possible that iso-
lated T cells in vitro are deprived of some factor(s) that is
available to them in vivo and that is essential for their exist-
ence.
To test the idea that the animal provides factors which
keep virgin T cells alive and which are absent in tissue cul-
ture, we studied the effects of various cytokines on the life
expectancy in vitro of T cells expressing a transgenic TCR.
We reasoned that most of the T cells in these animals
would not have been previously exposed to antigen and
therefore would be virgin, resting cells. Experiments showed
that these cells died readily in vitro but that their death
could be prevented by addition of IL-4 or IL-7. Levels of
the survival-related proteins, Bcl-2 and Bcl-X
 
l
 
 (11–15),
dropped rapidly in T cells after they were isolated from an-
imals and placed in tissue culture. Culture with IL-4 pre-
vented this drop, suggesting that the effects of IL-4 on T
cell survival might be due to its ability to maintain Bcl-2
levels in T cells. IL-4 prevented T cell death even if the
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cells came from a Stat6-deficient animal, although slightly
higher amounts of IL-4 were required to achieve the res-
cue. Stat6 is a signaling protein often associated with IL-4
driven effects. Thus, IL-4 and IL-7, which share the 
 
g
 
c in
their receptors (9), may affect T cell survival via some com-
mon signaling pathway that does not involve Stat6.
 
Materials and Methods
 
Mice.
 
The AD10 TCR reacts with a peptide from pigeon cy-
tochrome c bound to I-E
 
k
 
 (16). Mice transgenic for this TCR
were the gift of Dr. S. Hedrick. They were bred in the Animal
Care Facility at the National Jewish Medical and Research Cen-
ter (Denver, CO). Normal C57BL/10 animals were purchased
from The Jackson Laboratory (Bar Harbor, ME). Stat6
 
2
 
/
 
2
 
 mice
(17, 18) were bred at the Animals Care Facility, St. Jude Chil-
dren’s Hospital (Memphis, TN). All mice were maintained under
specific pathogen-free conditions.
 
Preparation and Culture of T Cells.
 
T cells were isolated by ny-
lon wool purification as previously reported (19), and resus-
pended at 5 
 
3
 
 10
 
6
 
 cells/ml in DMEM supplemented with 10% of
a batch of fetal bovine serum previously tested for its ability to
maintain hybridoma cells at excellent viability. The medium also
contained essential and nonessential amino acids (GIBCO BRL,
Gaithersburg, MD), 5 
 
3
 
 10
 
2
 
5
 
 M 2-mercaptoethanol, sodium
pyruvate, glutamine, and antibiotics (20). Cultures were set up in
96-well tissue culture plates at 100 
 
m
 
l/well. Cytokines were
added at the beginning of the culture period at the indicated con-
centrations. IL-4 was obtained from Genzyme (Cambridge, MA).
The other cytokines were purchased from R&D Systems, (Min-
neapolis, MN).
 
Analysis of Cell Death.
 
At the time that the T cells were iso-
lated and 24 and 48 h thereafter, samples of the cells were stained
to measure their DNA content as previously described (21). In
brief, the 96-well plates were spun, and supernatant removed
from the wells by gentle dumping. A DNA staining mixture,
comprised of 5 
 
m
 
g/ml propidium iodide (PI)
 
1
 
, 0.3% saponin
(both from Sigma Chem. Co., St. Louis, MO), 5 mM EDTA and
50 
 
m
 
g/ml RNAse (Boehringer Mannheim, Indianapolis, IN) was
then added as 180 
 
m
 
l to each well. The plates were left at room
temperature for 30 min and then kept on ice. These last two pro-
cedures were carried out in the dark. The intensity of PI staining,
a measure of DNA content, was assayed using a Becton Dickin-
son FACScan
 
Ò
 
 instrument (Beckton Dickinson, Immunocytome-
try Systems, San Jose, CA).
 
Immunoprecipitation and Western Blots.
 
Lymph node T cells were
isolated and cultured at 5 
 
3
 
 10
 
6
 
 cells/ml as described above. At 0,
4, 24, and/or 48 h T cells were lysed in 0.5% NP-40, 20 mM
Hepes, pH 7.2, 100 mM NaCl, 2 mM DTT, 1 mM EDTA, 1.0
mM PMSF, 1 
 
m
 
g/ml aprotinin (all reagents purchased from
Sigma). The nuclei were pelleted for 10 min at 14,000 rpm in the
cold in a microfuge. Supernatants were removed and 2 
 
3
 
 10
 
6
 
 cell
equivalents were fractionated by SDS-PAGE, using 10% acryl-
amide, and blotted onto Immobilon PVDF membranes (Milli-
pore, Bedford, MA) using a Trans-Blot apparatus (BioRad, Free-
mont, CA) for 30 min at 15 V. Blots were blocked with 5%
powdered milk in Tris-buffered saline pH 7.5, Bcl-2 and Bcl-X
 
l
 
were detected with rabbit polyclonal antibodies purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). A goat anti–rabbit
Ig peroxidase-conjugated antibody (Boehringer Mannheim) was
used as the secondary reagent. Bands were detected using Amer-
sham ECL reagents (Arlington Heights, IL).
For analysis of Stat6 phosphorylation, T cells were cultured
with and without IL-4 as described above. Nuclear lysates were
generated by resuspending T cells in 20 mM Hepes, pH 7.9, 300
mM sucrose, 10 mM KCl, 1.5 mM MgCl
 
2
 
 with protease inhibi-
tors. The cells were allowed to swell for 5 min and then spun.
Cells were Dounce homogenized and spun. The nuclei were re-
suspended in 20 mM Hepes, pH 7.9, 300 mM sucrose, 420 mM
NaCl, 1.5 mM MgCl
 
2
 
 with protease inhibitors. After a 30-min
incubation on ice, exuded nuclear proteins were immunpreci-
pated with anti-phosphotyrosine antibody (Santa Cruz Biotech-
nology), followed by precipitation with protein G PLUS–agarose
(Santa Cruz Biotechnology). Immunoprecipitates were fraction-
ated by SDS-PAGE and immunoblotted for the presence of Stat6
using rabbit polyclonal anti-Stat6 (Santa Cruz Biotechnology).
Bands bound to the rabbit antibody were detected as described
above.
 
Results and Discussion
 
Two Cytokines, IL-4 and IL-7, Prevent the Death In Vitro of
Resting T Cells.
 
T cells bearing the transgenic TCR, AD10,
were purified from the lymph node cells of young mice
and set up in culture. Most of these cells were resting cells
that had not been exposed to antigen, as judged by their small
size, low frequency (
 
,
 
10%) of CD69 expression, and
maintenance of a TCR, AD10, not expected to engage en-
vironmental antigens. At 0 time and 24 or 48 h later, via-
bility of the cells was assessed by measuring the amount of
DNA they contained, using PI (21). Cells that have died by
apoptosis, the primary mechanism of death in these cul-
Figure 1. Resting T cells die in culture. This death is inhibited by cul-
ture with IL-4 or IL-7. Resting lymph node T cells from AD10 TCR
transgenic mice were cultured at 2 3 105 cells/well with or without 100
U/ml of IL-4 or IL-7 for 24 and 48 h. Before culture, ,5% of the cells
contained ,2 N DNA. After culture, cells were stained with propidum
iodide and analyzed by flow cytometry to determine DNA content. The
number given in each histogram is the percent of T cells that were apop-
totic as defined by DNA content. Results shown are typical of three inde-
pendent experiments.
 
1
 
Abbreviation used in this paper:
 
 PI, propidium iodide. 
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tures, degrade their DNA into small fragments, consequently
the nuclei of such cells contain less than 2 N DNA.
Sample data from such an experiment are shown in Fig. 1.
Before culture less than 5% of the cells were dead. How-
ever, 24 and 48 h later 50 and 77%, of the cells had died re-
spectively.
Using this assay, we measured the effects of various cy-
tokines on the appearance of dead cells in vitro. To do this,
T cells were cultured for 24 or 48 h in the presence or ab-
sence of the cytokines, used at concentrations above those
known to be active in vitro as judged by publications on
the subject and the manufacturer’s recommendations. Many
cytokines had no effect on the death of resting T cells in
culture. Such cytokines included IL-1
 
b
 
, IL-3, IL-5, huIL-8,
IL-9, IL-10, IL-12, IFN-
 
g
 
, TNF-
 
a
 
, TNF-
 
b
 
, RANTES,
MIP-1
 
a
 
, MIP-1
 
b
 
, MIP-2, vascular endothelial growth fac-
tor (VEGF), platelet-derived endothelial cell growth factor
(PEGF), and TGF-
 
b
 
. As we have previously reported, IL-6
proved to be an excellent survival factor (22; data not
shown). However, we were surprised to find that two
other cytokines, IL-4 and IL-7, also rescued resting T cells
from death in culture very effectively. For example, as
shown in Fig. 1 
 
a
 
, addition of IL-4 or IL-7 reduced the
percent of dead cells after 24-h culture from 50% to 15 or
20%, respectively.
Titrations were performed to compare the relative effi-
cacy of the two cytokines (Fig. 2). On a nanograms per
milliliter basis, IL-4 was somewhat more effective than IL-7,
with a half-maximal effect at about 2 ng/ml (
 
z
 
10
 
2
 
10
 
 M)
versus 50 ng/ml (
 
z
 
3 
 
3
 
 10
 
2
 
9
 
 M) for IL-7. The effective
concentration of IL-4 matched well with the dissociation
constant of its high affinity receptor, 10
 
2
 
10
 
 M (23). How-
ever, the dissociation constant of the high affinity IL-7 re-
ceptor is reported to be only slightly greater, at 2 
 
3
 
 10
 
2
 
10
 
 M
(24). Collectively, these data suggest that IL-4 may be act-
ing via its high affinity receptor, whereas IL-7 may act via
some combination of high and low affinity receptors (the
latter have 
 
K
 
d
 
s of 10
 
2
 
8
 
 M).
Two other cytokines, IL-2 and IL-15, also had, at very
high concentrations, some effect on the viability of the cul-
tured cells (Fig. 2). Their effects were small but reproduc-
ible in several assays. We believe that these small effects
may have been due to engagement of these cytokines by
low affinity forms of their receptors. Resting T cells are
thought not to bear high affinity receptors for IL-2 and
perhaps also IL-15.
IL-4 and IL-7 did not inhibit death by inducing cell cy-
cle progression, because at 24 and 48 h T cells cultured
with these cytokines were still in G0/G1 and did not con-
tain more than 2-N amounts of DNA (see Fig. 1; data not
shown). Thus, these two cytokines acted as true survival
factors in this assay.
 
Culture with IL-4 Maintains Bcl-2 Levels in Resting T
Cells.
 
In many cases, lymphocyte survival is affected by
proteins in the Bcl-2 family (11–15). Therefore, we tested
whether culture in IL-4 had any effect on the levels of Bcl-2
and/or Bcl-X
 
l
 
 in the T cells. Purified resting T cells were
cultured with or without IL-4 for 4, 24, and 48 h. At each
timepoint, cells were lysed and lysates were electropho-
resed in SDS polyacrylamide gels. The proteins were trans-
ferred onto immobilon and probed with antibodies di-
Figure 2. Related cytokines, IL-4 and IL-7, rescue resting T cells from
apoptosis. T cells were purified from the lymph nodes of AD10 TCR
transgenic mice and 2 3 105 cells were cultured in triplicate for 24 h with
IL-2 (h), IL-4 (j), IL-7 (d), IL-9 (e), IL-13 (s), and IL-15 (n) at the
concentrations shown. At 24 h, the T cells were stained with PI and the
mean percent 6 SD of apoptotic cells was determined by flow cytometry.
Figure 3. IL-4 prevents decay of Bcl-2 and Bcl-Xl but not phosphory-
lated Stat6. Lymph node T cells from AD10 TCR transgenic mice were
cultured in the presence or absence of 25–50 U/ml of IL-4 for 0, 4, 24,
and 48 h (IL-4 was added at 0 and 24 h). At these times T cells were lysed
and proteins fractionated by SDS-PAGE. After transfer onto immobilon,
BCL-2 (a) and BCL-Xl (b) were detected by immunoblotting. (c) T cells
were incubated with or without IL-4 for 0, 4, and 24 h. Nuclear lysates
were immunoprecipitated with anti-phosphotyrosine and immunoblotted
for the presence of Stat6. 
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rected to Bcl-2 or Bcl-X
 
l
 
. At time 0 h, the T cell lysates
contained moderate levels of Bcl-2, which began to disap-
pear at 4 h and were even lower at 24 and 48 h (Fig. 3 
 
a
 
).
Bcl-X
 
l
 
 disappeared with similar kinetics, although it was
less easily detectable in the starting population (Fig. 3 
 
b
 
). By
contrast, lysates of cells cultured with IL-4 continued to
express Bcl-2 and the small amounts of Bcl-X
 
l
 
 at 4, 24, and
even 48 h. In fact, levels of Bcl-2 appeared higher in cells
cultured for 24 or 48 h in IL-4 than they were in cells be-
fore culture. These data support the idea that IL-4 acts by
regulating the levels of Bcl-2–related proteins in T cells.
It is well known that IL-4 transduces signals through a
JAK/Stat pathway (17, 19, 25–28). The IL-4 receptor (IL-4R)
is made up of the IL-2R common 
 
g
 
 chain and a ligand-
specific 
 
a
 
 chain (9, 23). The common 
 
g
 
 chain associates with
JAK3 and the 
 
a
 
 chain with JAK1 (25, 26). Upon ligation,
Stat6 associates with the IL-4R complex and is tyrosine
phosphorylated by JAK1 (27-31). Activated Stat6 forms
homodimers and translocates to the nucleus (27). Because
Stat6 is activated by IL-4R ligation, we hypothesized that
Stat6 may be responsible for transducing the T cell survival
signal delivered by IL-4.
To test this, we compared the effects of IL-4 on the sur-
vival of resting T cells from Stat6-deficient (Stat6
 
2
 
/
 
2
 
) and
normal mice (17, 18). The results are shown in Fig. 4 
 
a
 
. In
the absence of added cytokines, T cells from Stat6
 
2
 
/
 
2
 
 mice,
like those from normal animals, died in culture. Increasing
doses of IL-4 prevented the death of T cells from both
types of animals. The sensitivity of the two types of cells to
IL-4 was slightly different, with the Stat6
 
2
 
/
 
2
 
 cells requiring
between two- and fivefold more IL-4 than normal T cells
for half-maximal rescue.
As a control we compared the sensitivity to IL-4 of B
cells from the two types of animals. B cell responses to IL-4
were measured by the ability of the cytokine to increase
MHC class II levels on the surfaces of the cells during 24 h
of culture. As shown in Fig. 4 b, high concentrations of IL-4
did induce increased amounts of class II on Stat6
 
2
 
/
 
2
 
 B cells.
Even so, at optimum IL-4 concentrations less class II ap-
peared on the knockout cells. Also, half-maximal induction
of class II B cells from Stat6
 
2
 
/
 
2
 
 mice required 
 
z20 times
more IL-4 than normal B cells did. It has previously been
reported that IL-4 could not induce class II expression on
Stat62/2 B cells (17, 18). However, the previous experi-
ments were done with low concentrations of IL-4, concen-
trations near the threshold required to observe the induc-
tion shown in Fig. 4 b.
These results suggested that the ability of IL-4 to rescue
resting T cells from death did not require the presence in T
cells of the transcription factor Stat6, which is usually asso-
ciated with IL-4 signal transduction (27–31). However, the
presence of Stat6 caused the rescuing signal to be delivered
slightly more efficiently, suggesting that the Stat6 pathway
might act to amplify the rescuing signal. This conclusion
was supported by the effects on Stat62/2 B cells of IL-4. As
in T cells, response to IL-4 occurred in Stat62/2 B cells, al-
though the response was considerably amplified in the
presence of Stat6. Alternatively, it was possible that rescue
required Stat6 and that the Stat62/2 cells contained some
very small residual Stat6 activity due to expression of a
modified Stat6 protein from the knocked out Stat6 gene
(18). If this latter explanation was correct, resting T cell re-
sponses to IL-4 were driven by lower amounts of signal
than B cell responses were.
However, cells from genetically deficient animals are not
always equivalent to those from normal mice. Sometimes
they use intracellular signaling pathways that are not em-
ployed by normal cells. Therefore, we did a second experi-
ment to find out whether or not Stat6 signaling was a com-
ponent of IL-4 rescue of normal resting T cells from death.
Figure 4. IL-4 blocks the death of resting T cells that lack Stat6. (a) Prevention of resting T cell death by IL-4 is only slightly affected by lack of Stat6
in the T cell. T cells from normal or Stat62/2 mice were purified and cultured at 1.2 3 105 cells/well with various concentrations of IL-4. 42 h later, cells
were harvested and assayed for dead cells using propidium iodide staining. Open symbols, T cells from normal mice; closed symbols, T cells from Stat62/2
mice. (b) Induction of class II is affected by lack of Stat6 in B cells. Spleen cells from normal or Stat62/2 mice were cultured at 3 3 105 cells/well with
various concentrations of IL-4. 42 h later, the cells were harvested and stained with FITC–anti-IAb a chain and phycoerythrin-labeled anti-B220. Data
shown are the mean anti-IAb fluorescences after gating on the B220 positive cells. Open symbols, B cells from normal mice; closed symbols, B cells from
Stat62/2 mice.329 Vella et al.
Nuclear lysates were prepared from resting T cells from
normal mice, after various times of culture with or without
IL-4. The lysates were immunoprecipitated with anti-
phosphotyrosine polyclonal sera, the precipitate was elec-
trophoresed, blotted onto immobilon, and probed with
anti-Stat6. As shown in Fig. 3 c, phosphorylated Stat6 was
present in resting T cells at the time they were harvested
from the animals. This material rapidly disappeared from
resting T cells cultured without cytokines and was not ap-
parent after as little as 4 h in culture. Phosphorylated Stat6
increased somewhat in amount during the first 4 h of cul-
ture of resting T cells with IL-4 but then decreased to lev-
els that were not detectable in T cells after 24 h in culture,
whether or not IL-4 was present.
These data indicated that an early event in the signaling
pathway whereby IL-4 rescued resting T cells from death
might involve Stat6. However, activated Stat6 did not have
to be in the cells permanently for rescue to occur. IL-4 pre-
vented the death of normal cultured T cells 24 and 48 h af-
ter the beginning of the culture, at a time when levels of
phosphorylated Stat6 were undetectable.
Collectively, these data suggest that Stat6 is not an essential
component of the intracellular signaling pathway whereby IL-4
prevents the death of normal resting T cells after 24 and 48 h.
Do either of the cytokines studied in these experiments
actually affect the life expectancy of mature resting T cells
in vivo? In an uninfected animal it is unlikely that IL-4 lev-
els are high enough to manage this. Resting B cells also
bear high affinity IL-4R, yet in animals they do not have
elevated class II MHC protein levels that would be ex-
pected of B cells exposed to inducing concentrations of IL-4
(32). However, during infections, IL-4 levels in lymphoid
tissues are certainly high enough to bind to high affinity IL-4R
and hence increase the half-lives of bystander resting T
cells. Under these circumstances, IL-4 may affect the life
expectancy of bystander resting T cells.
On the other hand, experiments suggest that IL-7 may
be at effective concentrations in lymphoid tissues, even in
uninfected animals, and IL-7 has already been reported to
affect T cell turnover time (7, 33). Future experiments will
determine whether IL-7 does affect T cell life expectancy
in vivo.
Finally, it is worth noting that cytokines are known to
increase the half-lives af activated T cells as well and that
the cytokines that do this (IL-2, IL-4, IL-7; references 34,
35) are either the same as or related to the two cytokines
identified here. Perhaps this is not a coincidence.
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